Evaluation of patients with COVID-19 and the United Kingdom mutations in a training and research hospital in Istanbul

Objective & Hypothesis:OBJECTIVE: This study aims to evaluate the patient clinics by studying Variant of Concern (VOC) Polymerase Chain Reaction (PCR) on conventional PCR-positive samples in a training and research hospital COVID test center in Istanbul.

📊

Key Findings & Data:METHODS: The study is a descriptive type and VOC PCR from all samples (from a total of 1300 samples) which detected positive by conventional PCR in a training and research hospital COVID test center between February 2 and 9, 2021.

💡

Conclusion & Impact:The statistical significance was taken as p

🔬Design:Research Article

📍Scope:2021 · 1300 samples

⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: This study aims to evaluate the patient clinics by studying Variant of Concern (VOC) Polymerase Chain Reaction (PCR) on conventional PCR-positive samples in a training and research hospital COVID test center in Istanbul. METHODS: The study is a descriptive type and VOC PCR from all samples (from a total of 1300 samples) which detected positive by conventional PCR in a training and research hospital COVID test center between February 2 and 9, 2021. The United Kingdom mutation (VOC 202012/01, B.1.1.7) has been studied. Clinics parameters of the patients were evaluated from Public Health Management System (HSYS) records. The statistical significance was taken as p

🔖

Cite This Article

Memisoglu, K., Yilmaz, H., Guner, A. E., Kazezoglu, C., Komurcu, S. Z. M., Maral, I., Cakir, M. (2022). Evaluation of patients with COVID-19 and the United Kingdom mutations in a training and research hospital in Istanbul. İstanbul Kuzey Klinikleri, Cilt: 8 - Sayı: 4, 317–320. https://ajindex.com/articles/551324

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (8)

World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. Available at: https://www.who. int/publications/i/item/WHO-2019-nCoV-clinical-2021-1. Accessed Jun 22, 2021
World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/. Accessed Feb 28, 2021
Candido DS, Claro IM, de Jesus JG, Souza WM, Moreira FRR, Dellicour S, et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020 Sep 4;369(6508):1255–60
World Health Organization. COVID-19 Weekly Epidemiological Update 25 February 2021. 2021. Available at: https:// www.who.int/docs/default-source/coronaviruse/situation-reports/20210225_weekly_epi_update_voc-special-edition.pdf. Accessed Jun 22, 2021
Borges V, Sousa C, Menezes L, Gonçalves AM, Picão M, Almeida JP, et al. Tracking SARS-CoV-2 VOC 202012/01 (lineage B. 1.1. 7) dissemination in Portugal: insights from nationwide RT-PCR Spike gene drop out data. Available at: https://virological.org/t/ tracking-sars-cov-2-voc-202012-01-lineage-b-1-1-7-dissemination-in-portugal-insights-from-nationwide-rt-pcr-spike-genedrop-out-data/600. Accessed Jun 22, 2021
Kupferschmidt K. Viral evolution may herald new pandemic phase. Science 2021;371:108–9
Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday J, et al. Estimated transmissibility and severity of novel SARSCoV-2 Variant of Concern 202012/01 in England. MedRxiv Dec 26, 2020, doi: 10.1126/science.abg3055
Leung K, Shum MH, Leung GM, Lam TT, Wu JT. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Euro Surveill 2021;26:2002106.